A Comprehensive Review On Digital Health Technologies In Pharmaceuticals: A Transformation For Patient Healthcare With Innovation And Precision

Abstract

Digital Health Technologies (DHTs) have revolutionized the healthcare industry by incorporating such tools as wearables, mobile applications, telemedicine, and electronic health records to improve patient care. The technologies increase accessibility, efficiency, and personalized treatment, particularly in medication adherence, chronic disease management, and clinical trials. To illustrate, mHealth apps and wearables have led to a 20-30% increase in medication adherence, and remote patient monitoring (RPM) has decreased hospital readmissions by as much as 38%. The COVID-19 pandemic has accelerated the adoption of telehealth, and it has offered continuity of care in the face of disruption around the world. DHTs can also enable personalized medicine through the use of AI and genomic technologies that enable more personalized treatment that has fewer side effects and better outcomes. However, concerns such as data confidentiality, regulatory adherence, and integration with existing systems remain significant. The mean healthcare data breach cost in 2023 was 9.23 million, which highlights the importance of such frameworks as HIPAA and GDPR. New technologies, including AI, blockchain, and advanced wearables, are likely to introduce further changes, including an effective drug development procedure, improved patient engagement, and secure data storage. The regulations should be revised to strike a balance between innovation and patient safety and interdisciplinary collaboration is the key to overcome technical and ethical challenges. DHTs are transforming healthcare delivery, and they present possibilities of patient-centered, data-driven care. The stakeholders should collaborate to address the challenges and achieve equitable access, which will eventually promote global health equity.